Abstract
Normocalciuric and hypercalciuric patients with idiopathic recurrent calcium nephrolithiasis were compared with healthy individuals without such a history to examine the factors that predispose normocalciuric patients to stone formation. The urine calcium excretion rate was higher in the normocalciuric patients than in the control subjects (227 v. 183 mg/24 h; P less than 0.01), but the urine calcium concentration was not significantly different. The urine magnesium and citrate excretion rates and concentrations were lower in the normocalciuric patients than in the control subjects (P less than 0.001), while the urine uric acid and oxalate excretion rates and concentrations and the urine saturation with brushite (CaHPO4-2H2O) were not significantly different. These results suggest the importance of slight increases in the urine calcium excretion rate together with decreased urine magnesium and citrate excretion rates in normocalciuric persons with recurrent calcium stone formation. The urine of the hypercalciuric patients was more highly saturated with brushite than the urine of the normocalciuric patients and the control subjects, and the excretion rates of uric acid and oxalate were increased in the hypercalciuric patients. The hypercalciuric patients had a higher urine creatinine excretion rate than the normocalciuric patients and a higher daily urine volume than the control subjects, which suggests that differences in lean body mass or fluid and food intake, or both, may be important determinants of these differences in crystalloid excretion. As in the normocalciuric patients, the urine citrate excretion rate and concentration were decreased in the hypercalciuric patients compared with the control subjects.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burdette D. C., Thomas W. C., Jr, Finlayson B. Urinary supersaturation with calcium oxalate before and during orthophosphate therapy. J Urol. 1976 Apr;115(4):418–422. doi: 10.1016/s0022-5347(17)59224-1. [DOI] [PubMed] [Google Scholar]
- Coe F. L. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977 Oct;87(4):404–410. doi: 10.7326/0003-4819-87-4-404. [DOI] [PubMed] [Google Scholar]
- Desmars J. F., Tawashi R. Dissolution and growth of calcium oxalate monohydrate. I. Effect of magnesium and pH. Biochim Biophys Acta. 1973 Jul 28;313(2):256–267. doi: 10.1016/0304-4165(73)90025-1. [DOI] [PubMed] [Google Scholar]
- Evans R. A., Forbes M. A., Sutton R. A., Watson L. Urinary excretion of calcium and magnesium in patients with calcium-containing renal stones. Lancet. 1967 Nov 4;2(7523):958–961. doi: 10.1016/s0140-6736(67)90795-7. [DOI] [PubMed] [Google Scholar]
- Fleisch H. Inhibitors and promoters of stone formation. Kidney Int. 1978 May;13(5):361–371. doi: 10.1038/ki.1978.54. [DOI] [PubMed] [Google Scholar]
- Marshall R. W., Robertson W. G. Nomograms for the estimation of the saturation of urine with calcium oxalate, calcium phosphate, magnesium ammonium phosphate, uric acid, sodium acid urate, ammonium acid urate and cystine. Clin Chim Acta. 1976 Oct 15;72(2):253–260. doi: 10.1016/0009-8981(76)90081-4. [DOI] [PubMed] [Google Scholar]
- Oreopoulos D. G., Soyannwo M. A., McGeown M. G. Magnesium-calcium ratio in urine of patients with renal stones. Lancet. 1968 Aug 24;2(7565):420–422. doi: 10.1016/s0140-6736(68)90464-9. [DOI] [PubMed] [Google Scholar]
- Robertson W. G., Morgan D. B. The distribution of urinary calcium excretions in normal persons and stone-formers. Clin Chim Acta. 1972 Mar;37:503–508. doi: 10.1016/0009-8981(72)90475-5. [DOI] [PubMed] [Google Scholar]
- Yendt E. R. Renal calculi. Can Med Assoc J. 1970 Mar 14;102(5):479–489. [PMC free article] [PubMed] [Google Scholar]